Matches in Wikidata for { <http://www.wikidata.org/entity/Q60473045> ?p ?o ?g. }
Showing items 1 to 49 of
49
with 100 items per page.
- Q60473045 description "article scientifique publié en 2017" @default.
- Q60473045 description "article" @default.
- Q60473045 description "wetenschappelijk artikel" @default.
- Q60473045 description "наукова стаття, опублікована у вересні 2017" @default.
- Q60473045 description "հոդված" @default.
- Q60473045 name "Efficacy of next treatment received after Nivolumab (Nivo) progression in patients (pts) with non-small-cell lung cancer (NSCLC)" @default.
- Q60473045 name "Efficacy of next treatment received after Nivolumab" @default.
- Q60473045 type Item @default.
- Q60473045 label "Efficacy of next treatment received after Nivolumab (Nivo) progression in patients (pts) with non-small-cell lung cancer (NSCLC)" @default.
- Q60473045 label "Efficacy of next treatment received after Nivolumab" @default.
- Q60473045 prefLabel "Efficacy of next treatment received after Nivolumab (Nivo) progression in patients (pts) with non-small-cell lung cancer (NSCLC)" @default.
- Q60473045 prefLabel "Efficacy of next treatment received after Nivolumab" @default.
- Q60473045 P1476 Q60473045-1D17A82A-EF37-468C-841D-DC1932CFE756 @default.
- Q60473045 P2093 Q60473045-2422693A-B757-4A4B-A654-8E80FA3403EA @default.
- Q60473045 P2093 Q60473045-4016BAB1-AF67-4AB6-91C0-A5722B460DBA @default.
- Q60473045 P2093 Q60473045-5BE1D004-287C-4EE4-A948-F81FBD7421B3 @default.
- Q60473045 P2093 Q60473045-66B22927-F7C9-41D5-88C5-4F20B875E7E6 @default.
- Q60473045 P2093 Q60473045-8525A048-855F-47AC-B99C-CBC8A93EFFA3 @default.
- Q60473045 P2093 Q60473045-95D40EF0-F306-4FFB-967E-536A9D0751D4 @default.
- Q60473045 P2093 Q60473045-9D8BE20D-798F-436C-A241-793E8A79AC94 @default.
- Q60473045 P2093 Q60473045-AA06889E-D917-4F11-85FE-BD86039C4E47 @default.
- Q60473045 P2093 Q60473045-AFBCDD45-209C-413E-BB8B-EC6C32A69992 @default.
- Q60473045 P2093 Q60473045-BA6AB066-5F91-4064-96A7-A20EE4E82576 @default.
- Q60473045 P2093 Q60473045-E742256F-986A-489E-A108-E89CA4B14299 @default.
- Q60473045 P2093 Q60473045-F4D538E5-92E3-4722-9E3F-A8CA235510F8 @default.
- Q60473045 P31 Q60473045-E30BB99C-91B6-4A53-A5FB-F0139D476E8F @default.
- Q60473045 P356 Q60473045-399B65E5-0CEF-4478-B4CB-C5FB20923327 @default.
- Q60473045 P50 Q60473045-15278855-3A7C-4821-A3F9-C65313851C59 @default.
- Q60473045 P50 Q60473045-1C4F8598-01DF-400A-A68C-AC92E76179F0 @default.
- Q60473045 P577 Q60473045-893DF4C5-D0B3-4436-A3BC-08D4DC83EDAB @default.
- Q60473045 P356 1393003.CONGRESS-2017.OA1476 @default.
- Q60473045 P1476 "Efficacy of next treatment received after Nivolumab (Nivo) progression in patients (pts) with non-small-cell lung cancer (NSCLC)" @default.
- Q60473045 P2093 "Adrien Costantini" @default.
- Q60473045 P2093 "Boris Duchemann" @default.
- Q60473045 P2093 "Etienne Giroux-Leprieur" @default.
- Q60473045 P2093 "Jean Tredaniel" @default.
- Q60473045 P2093 "Jennifer Corny" @default.
- Q60473045 P2093 "Laurent Taillade" @default.
- Q60473045 P2093 "Ludovic Doucet" @default.
- Q60473045 P2093 "Marie Wislez" @default.
- Q60473045 P2093 "Sophie Renet" @default.
- Q60473045 P2093 "Stéphane Jouveshomme" @default.
- Q60473045 P2093 "Sylvie Friard" @default.
- Q60473045 P2093 "Vincent Fallet" @default.
- Q60473045 P31 Q13442814 @default.
- Q60473045 P356 "10.1183/1393003.CONGRESS-2017.OA1476" @default.
- Q60473045 P50 Q115583696 @default.
- Q60473045 P50 Q57027992 @default.
- Q60473045 P577 "2017-09-01T00:00:00Z" @default.